PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding ▲ | PubMed ID |
---|---|---|---|---|---|---|---|
Lectin-hemagglutinin adhesins
|
Blood group Lewis b (Leb) antigen
|
Oligosaccharides
|
Not Binding
|
||||
Lectin-hemagglutinin adhesins
|
Blood group Lewis b (Leb) antigen
|
Oligosaccharides
|
Not Binding
|
||||
Lectin-hemagglutinin adhesins
|
Blood group Lewis b (Leb) antigen
|
Oligosaccharides
|
Not Binding
|
||||
Lectin-hemagglutinin adhesins
|
Blood group Lewis b (Leb) antigen
|
Oligosaccharides
|
Not Binding
|
||||
NeuC protein of K1 capsule (UDP GlcNAc 2-epimerase))
|
GlcNAc-6-P
|
Saccharides
|
Not Binding
|
||||
Neutrophil-activating proteins (150-kDa)
|
NeuGc3-Lc4Cer (Sialyl lactotetraosylceramide)
|
Sialoglycosphingolipids
|
Rabbit thymus
|
NeuGc(a2-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Unknown
|
NeuGc3-nLc6Cer
|
Sialoglycosphingolipids
|
Human colon adenocarcinoma cells (WiDr )
|
NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Neutrophil-activating proteins (150-kDa)
|
unnamed ligand
|
Sialoglycosphingolipids
|
Human erythrocytes
|
Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Unknown
|
unnamed ligand
|
Oligoglycosylceramides
|
Human erythrocytes
|
GalNAc(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Unknown
|
Lewis x (Lex) (GSL)
|
Oligoglycosylceramides
|
Dog small intestine
|
Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01